Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Venovenous extracorporeal membrane oxygenation (VV-ECMO) is a form of mechanical respiratory support therapy for patients with acute lung injury or end-stage lung disease. Clinical demand for VV-ECMO has increased substantially, yet consensus on optimal patient management strategies remains limited. ECMO physiology is complex and difficult to predict, given the three-way interactions between the patient, the mechanical ventilator, and the extracorporeal circuit.
Abstract Objective The effect of anticoagulation therapy (AC) on hemodialysis access patency and related complications is not well defined. Patients on long-term or chronic AC due to their underlying comorbid conditions may be particularly susceptible to access-related bleeding and complications from repetitive cannulation. Our goal is to assess the effect of anticoagulation therapy on outcomes after access creation.
For assistance, please contact: AAN Members (800) 879-1960 or (612) 928-6000 (International) Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international) Sign Up Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found Purchase Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00.
Determination of death by neurologic criteria around the world Ariane Lewis, Azza Bakkar, Elana Kreiger-Benson, Andrew Kumpfbeck, Jordan Liebman, Sam D. Shemie, Gene Sung, Sylvia Torrance, David Greer Neurology Jun 2020, 10.1212/WNL.0000000000009888; DOI: 10.1212/WNL.0000000000009888
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
